Experimental results indicate that lucidone reduces the levels of the anti-apoptotic protein Bcl-xL and increases the ratio of the pro-apoptotic protein Bax/Bcl-xL in human pancreatic cancer MIA Paca-2 cells. Here, BAX is linked to pancreatic neoplasm.